Inovio Pharmaceuticals Ownership 2024 | Who Owns Inovio Pharmaceuticals Now?
Institutional Ownership
0.05%
Insider Ownership
0.85%
Retail Ownership
99.11%
Institutional Holders
3.00
Inovio Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IFP ADVISORS, INC | - | - | - | -175 | -100.00% | - | Jun 30, 2024 |
| PRIME CAPITAL INVESTMENT ADVISORS, LLC | - | - | - | -10,172 | -100.00% | - | Jun 30, 2024 |
| SACHETTA, LLC | - | - | - | -3 | -100.00% | - | Jun 30, 2024 |
Inovio Pharmaceuticals's largest institutional shareholder is IFP ADVISORS, INC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IFP ADVISORS, INC | - | - | - | -175 | -100.00% | - | Jun 30, 2024 |
| PRIME CAPITAL INVESTMENT ADVISORS, LLC | - | - | - | -10,172 | -100.00% | - | Jun 30, 2024 |
| SACHETTA, LLC | - | - | - | -3 | -100.00% | - | Jun 30, 2024 |
The largest Inovio Pharmaceuticals shareholder by % of total assets is IFP ADVISORS, INC. The company owns 0.00 shares of Inovio Pharmaceuticals (INO), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SACHETTA, LLC | - | - | - | -3 | -100.00% | - | Jun 30, 2024 |
| IFP ADVISORS, INC | - | - | - | -175 | -100.00% | - | Jun 30, 2024 |
| PRIME CAPITAL INVESTMENT ADVISORS, LLC | - | - | - | -10,172 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Inovio Pharmaceuticals's largest institutional buyer is SACHETTA, LLC. The company purchased -3.00 stocks of INO, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PRIME CAPITAL INVESTMENT ADVISORS, LLC | - | - | - | -10,172 | -100.00% | - | Jun 30, 2024 |
| IFP ADVISORS, INC | - | - | - | -175 | -100.00% | - | Jun 30, 2024 |
| SACHETTA, LLC | - | - | - | -3 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Inovio Pharmaceuticals's biggest institutional seller is PRIME CAPITAL INVESTMENT ADVISORS, LLC. The company sold -10.17K shares of INO, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PRIME CAPITAL INVESTMENT ADVISORS, LLC | - | - | - | -10,172 | -100.00% | - | Jun 30, 2024 |
| IFP ADVISORS, INC | - | - | - | -175 | -100.00% | - | Jun 30, 2024 |
| SACHETTA, LLC | - | - | - | -3 | -100.00% | - | Jun 30, 2024 |
Inovio Pharmaceuticals's largest sold out institutional shareholder by shares sold is PRIME CAPITAL INVESTMENT ADVISORS, LLC, sold -10.17K shares, valued at -, as of undefined.
Inovio Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC | 0.63% | 500,000 | - | - | Dec 29, 2023 |
| BANCROFT FUND LTD | 0.54% | 750,000 | - | - | Dec 29, 2023 |
| ELLSWORTH GROWTH & INCOME FUND LTD | 0.53% | 750,000 | - | - | Dec 29, 2023 |
| WASATCH FUNDS TRUST | 0.45% | 4,202,599 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.44% | 10,316,270 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.34% | 175,516 | - | - | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.22% | 319,165 | - | - | Feb 29, 2024 |
| Vericimetry Funds | 0.18% | 16,420 | - | - | Mar 31, 2024 |
| BANCROFT FUND LTD | 0.18% | 250,000 | - | - | Dec 29, 2023 |
| ELLSWORTH GROWTH & INCOME FUND LTD | 0.18% | 250,000 | - | - | Dec 29, 2023 |
| TEKLA HEALTHCARE INVESTORS | 0.16% | 138,090 | - | - | Mar 31, 2024 |
| GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC | 0.16% | 125,000 | - | - | Dec 29, 2023 |
| TEKLA LIFE SCIENCES INVESTORS | 0.14% | 63,948 | - | - | Mar 31, 2024 |
| Ark ETF Trust | 0.11% | 902,521 | - | - | Jan 31, 2024 |
| REYNOLDS FUNDS INC | 0.11% | 1,200 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.10% | 2,305 | - | - | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.09% | 283,791 | - | - | Feb 29, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.07% | 39,964 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.06% | 389,992 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.05% | 9,407 | - | - | Mar 28, 2024 |
| ALGER FUNDS | 0.04% | 40,000 | - | - | Jan 31, 2024 |
| ETFis Series Trust I | 0.04% | 54,106 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.04% | 15,202,384 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.03% | 6,194 | - | - | Mar 31, 2024 |
| NEXPOINT FUNDS I | 0.03% | 100,000 | - | - | Dec 31, 2023 |
| VANGUARD EXPLORER FUND | 0.02% | 297,224 | - | - | Jan 31, 2024 |
| ProFunds | 0.02% | 275,966 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.02% | 253,076 | - | - | Feb 29, 2024 |
| Nushares ETF Trust | 0.02% | 135,656 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.02% | 2,700,219 | - | - | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.02% | 42,565 | - | - | Jan 31, 2024 |
| FIDELITY FINANCIAL TRUST | 0.02% | 299,000 | - | - | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.02% | 60,816 | - | - | Jan 31, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 74,102 | - | - | Mar 31, 2020 |
| MASTER ADVANTAGE SMID CAP LLC | 0.01% | 1,501 | - | - | Dec 31, 2020 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 2,155,211 | - | - | Feb 29, 2024 |
| ETF Managers Trust | 0.01% | 69,214 | -8,233 | -10.63% | Dec 31, 2023 |
| FIDELITY COVINGTON TRUST | 0.01% | 142,619 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.01% | 195,712 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.01% | 16,212 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.01% | 68,349 | - | - | Mar 31, 2024 |
| Bernstein Fund Inc | 0.00% | 40,330 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 11,331 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 919,825 | - | - | Feb 29, 2024 |
| SSGA FUNDS | 0.00% | 1,414 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 132,910 | - | - | Feb 29, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 255,521 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 93,170 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 1,293 | - | - | Apr 30, 2021 |
| SCHWAB STRATEGIC TRUST | 0.00% | 1,368,485 | - | - | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 14,927 | - | - | Aug 31, 2023 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 106,466 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 130,844 | - | - | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 7,287 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 26,465 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 166,352 | - | - | Mar 28, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 5,600 | - | - | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 900 | - | - | Dec 31, 2023 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 70,311 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 12,778 | - | - | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 5,200 | - | - | Mar 28, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 95,598 | - | - | Mar 28, 2024 |
| Meeder Funds | 0.00% | 4,053 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 866,706 | - | - | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 57,101 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 843,718 | - | - | Mar 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 22,031,597 | - | - | Mar 31, 2024 |
| PRUDENTIAL SERIES FUND | 0.00% | 43,567 | - | - | Mar 28, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 2,117,801 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 2,823 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 59,451 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 11,181 | - | - | Feb 29, 2024 |
| NEW COVENANT FUNDS | 0.00% | 2,095 | - | - | Dec 31, 2023 |
| RYDEX SERIES FUNDS | 0.00% | 2,008 | - | - | Dec 31, 2023 |
| THRIVENT MUTUAL FUNDS | 0.00% | 43,175 | - | - | Mar 28, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 55,300 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 893,855 | - | - | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 2,464 | - | - | Feb 29, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 1,607 | - | - | Mar 28, 2024 |
| TIAA-CREF FUNDS | 0.00% | 1,155,285 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 1,508 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 9,800 | - | - | Mar 28, 2024 |
| VALIC Co I | 0.00% | 90,979 | - | - | Feb 29, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 4,890 | - | - | Mar 31, 2024 |
| Tidal ETF Trust | 0.00% | 3,923 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 37,587 | - | - | Mar 31, 2024 |
| FundVantage Trust | 0.00% | 4,215 | - | - | Mar 28, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 11,075 | 11,075 | - | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 21,321 | 21,321 | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 79,072 | - | - | Jan 31, 2024 |
| Victory Portfolios II | 0.00% | 13,129 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 1,004 | - | - | Dec 31, 2023 |
| HC CAPITAL TRUST | 0.00% | 7,364 | - | - | Mar 31, 2024 |
| Amplify ETF Trust | 0.00% | 5,854 | 5,854 | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 18,125 | - | - | Mar 31, 2024 |
| Chartwell Funds | 0.00% | 4,288 | - | - | Jun 30, 2022 |
| MAINSTAY FUNDS TRUST | 0.00% | 41,200 | - | - | Jan 31, 2024 |
| Pacer Funds Trust | 0.00% | 8,232 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 172,894 | - | - | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 145 | - | - | Dec 31, 2023 |
Inovio Pharmaceuticals's largest mutual fund holder by % of total assets is "GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC", owning 500.00K shares, compromising 0.63% of its total assets.
Inovio Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 3 | -97.30% |
| 31 Dec, 23 | 111 | -11.90% |
| 30 Sep, 23 | 126 | -5.97% |
| 30 Jun, 23 | 134 | -23.86% |
| 31 Mar, 23 | 176 | -6.38% |
| 31 Dec, 22 | 188 | 11.90% |
| 30 Sep, 22 | 168 | 1.82% |
| 30 Jun, 22 | 165 | -12.23% |
| 31 Mar, 22 | 188 | -10.05% |
| 31 Dec, 21 | 209 | -4.57% |
| 30 Sep, 21 | 219 | -1.79% |
| 30 Jun, 21 | 223 | -4.29% |
| 31 Mar, 21 | 233 | -2.92% |
| 31 Dec, 20 | 240 | -3.23% |
| 30 Sep, 20 | 248 | 0.81% |
| 30 Jun, 20 | 246 | 41.38% |
| 31 Mar, 20 | 174 | 61.11% |
| 31 Dec, 19 | 108 | -6.90% |
| 30 Sep, 19 | 116 | -9.38% |
| 30 Jun, 19 | 128 | 3.23% |
| 31 Mar, 19 | 124 | - |
| 31 Dec, 18 | 124 | -5.34% |
| 30 Sep, 18 | 131 | 3.97% |
| 30 Jun, 18 | 126 | -3.08% |
| 31 Mar, 18 | 130 | -2.26% |
| 31 Dec, 17 | 133 | 1.53% |
| 30 Sep, 17 | 131 | 3.15% |
| 30 Jun, 17 | 127 | 13.39% |
| 31 Mar, 17 | 112 | -16.42% |
| 31 Dec, 16 | 134 | -1.47% |
| 30 Sep, 16 | 136 | -3.55% |
| 30 Jun, 16 | 141 | 11.90% |
| 31 Mar, 16 | 126 | -1.56% |
| 31 Dec, 15 | 128 | 8.47% |
| 30 Sep, 15 | 118 | 10.28% |
| 30 Jun, 15 | 107 | 4.90% |
| 31 Mar, 15 | 102 | 6.25% |
| 31 Dec, 14 | 96 | 9.09% |
| 30 Sep, 14 | 88 | 7.32% |
| 30 Jun, 14 | 82 | - |
As of 31 Mar 24, 3 institutions are holding Inovio Pharmaceuticals's shares, representing a decrease of -97.30% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 10,350 | -99.98% |
| 31 Dec, 23 | 49,831,646 | -10.29% |
| 30 Sep, 23 | 55,546,864 | -22.55% |
| 30 Jun, 23 | 71,715,080 | -41.07% |
| 31 Mar, 23 | 121,702,472 | -4.35% |
| 31 Dec, 22 | 127,241,277 | 9.78% |
| 30 Sep, 22 | 115,901,200 | 2.27% |
| 30 Jun, 22 | 113,328,803 | 23.25% |
| 31 Mar, 22 | 91,947,908 | 6.99% |
| 31 Dec, 21 | 85,941,089 | 11.04% |
| 30 Sep, 21 | 77,399,140 | 5.30% |
| 30 Jun, 21 | 73,502,159 | -1.49% |
| 31 Mar, 21 | 74,613,791 | 12.57% |
| 31 Dec, 20 | 66,280,947 | 6.39% |
| 30 Sep, 20 | 62,297,204 | 10.14% |
| 30 Jun, 20 | 56,564,042 | 28.78% |
| 31 Mar, 20 | 43,921,704 | -9.84% |
| 31 Dec, 19 | 48,717,775 | 4.47% |
| 30 Sep, 19 | 46,631,834 | -0.15% |
| 30 Jun, 19 | 46,702,815 | 2.20% |
| 31 Mar, 19 | 45,698,373 | 28.39% |
| 31 Dec, 18 | 35,594,203 | 8.92% |
| 30 Sep, 18 | 32,680,100 | 12.99% |
| 30 Jun, 18 | 28,923,247 | -3.85% |
| 31 Mar, 18 | 30,080,506 | 5.13% |
| 31 Dec, 17 | 28,613,532 | -1.54% |
| 30 Sep, 17 | 29,061,535 | 30.13% |
| 30 Jun, 17 | 22,333,039 | 11.92% |
| 31 Mar, 17 | 19,955,164 | -2.29% |
| 31 Dec, 16 | 20,421,897 | -3.38% |
| 30 Sep, 16 | 21,135,719 | 0.55% |
| 30 Jun, 16 | 21,021,112 | 4.74% |
| 31 Mar, 16 | 20,069,268 | -13.79% |
| 31 Dec, 15 | 23,280,360 | -5.53% |
| 30 Sep, 15 | 24,643,125 | 4.35% |
| 30 Jun, 15 | 23,615,259 | 25.66% |
| 31 Mar, 15 | 18,792,327 | 6.99% |
| 31 Dec, 14 | 17,564,633 | 25.80% |
| 30 Sep, 14 | 13,961,985 | 21.83% |
| 30 Jun, 14 | 11,460,081 | - |
Inovio Pharmaceuticals (INO) has 10.35K shares outstanding as of 31 Mar 24, down -99.98% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 0.05% | 0.01% |
| 31 Dec, 23 | 18.55% | 4.20% |
| 30 Sep, 23 | 21.01% | 2.73% |
| 30 Jun, 23 | 27.75% | 1.25% |
| 31 Mar, 23 | 47.09% | 1.66% |
| 31 Dec, 22 | 53.32% | 2.47% |
| 30 Sep, 22 | 46.48% | 2.00% |
| 30 Jun, 22 | 48.17% | 2.73% |
| 31 Mar, 22 | 42.00% | 2.51% |
| 31 Dec, 21 | 40.87% | 3.02% |
| 30 Sep, 21 | 36.80% | 2.99% |
| 30 Jun, 21 | 35.07% | 2.58% |
| 31 Mar, 21 | 36.86% | 2.02% |
| 31 Dec, 20 | 42.73% | 3.01% |
| 30 Sep, 20 | 37.67% | 2.86% |
| 30 Jun, 20 | 36.30% | 2.92% |
| 31 Mar, 20 | 35.24% | 1.45% |
| 31 Dec, 19 | 49.35% | 2.22% |
| 30 Sep, 19 | 47.10% | 2.08% |
| 30 Jun, 19 | 47.62% | 2.17% |
| 31 Mar, 19 | 46.87% | 3.17% |
| 31 Dec, 18 | 38.46% | 3.08% |
| 30 Sep, 18 | 35.36% | 3.51% |
| 30 Jun, 18 | 31.73% | 2.87% |
| 31 Mar, 18 | 33.26% | 2.72% |
| 31 Dec, 17 | 34.99% | 3.13% |
| 30 Sep, 17 | 33.42% | 3.81% |
| 30 Jun, 17 | 29.62% | 4.09% |
| 31 Mar, 17 | 26.91% | 3.46% |
| 31 Dec, 16 | 27.89% | 3.38% |
| 30 Sep, 16 | 28.72% | 3.46% |
| 30 Jun, 16 | 28.81% | 3.73% |
| 31 Mar, 16 | 27.79% | 2.38% |
| 31 Dec, 15 | 34.14% | 2.92% |
| 30 Sep, 15 | 34.21% | 2.81% |
| 30 Jun, 15 | 34.90% | 3.65% |
| 31 Mar, 15 | 30.94% | 3.51% |
| 31 Dec, 14 | 29.71% | 5.56% |
| 30 Sep, 14 | 23.12% | 6.39% |
| 30 Jun, 14 | 19.03% | - |
As of 31 Mar 24, Inovio Pharmaceuticals is held by 0.05% institutional shareholders, representing a 0.01% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 1 | -97.44% |
| 31 Dec, 23 | 39 | -9.30% |
| 30 Sep, 23 | 43 | -12.24% |
| 30 Jun, 23 | 49 | -30.00% |
| 31 Mar, 23 | 70 | -30.69% |
| 31 Dec, 22 | 101 | 31.17% |
| 30 Sep, 22 | 77 | -8.33% |
| 30 Jun, 22 | 84 | 15.07% |
| 31 Mar, 22 | 73 | -23.96% |
| 31 Dec, 21 | 96 | 7.87% |
| 30 Sep, 21 | 89 | -19.82% |
| 30 Jun, 21 | 111 | -10.48% |
| 31 Mar, 21 | 124 | 3.33% |
| 31 Dec, 20 | 120 | -14.89% |
| 30 Sep, 20 | 141 | -18.50% |
| 30 Jun, 20 | 173 | 50.43% |
| 31 Mar, 20 | 115 | 121.15% |
| 31 Dec, 19 | 52 | 20.93% |
| 30 Sep, 19 | 43 | -25.86% |
| 30 Jun, 19 | 58 | -7.94% |
| 31 Mar, 19 | 63 | 16.67% |
| 31 Dec, 18 | 54 | -18.18% |
| 30 Sep, 18 | 66 | 32.00% |
| 30 Jun, 18 | 50 | -13.79% |
| 31 Mar, 18 | 58 | - |
| 31 Dec, 17 | 58 | -21.62% |
| 30 Sep, 17 | 74 | 34.55% |
| 30 Jun, 17 | 55 | 41.03% |
| 31 Mar, 17 | 39 | -23.53% |
| 31 Dec, 16 | 51 | 15.91% |
| 30 Sep, 16 | 44 | -24.14% |
| 30 Jun, 16 | 58 | -1.69% |
| 31 Mar, 16 | 59 | 1.72% |
| 31 Dec, 15 | 58 | -6.45% |
| 30 Sep, 15 | 62 | -11.43% |
| 30 Jun, 15 | 70 | 25.00% |
| 31 Mar, 15 | 56 | 16.67% |
| 31 Dec, 14 | 48 | -12.73% |
| 30 Sep, 14 | 55 | -25.68% |
| 30 Jun, 14 | 74 | - |
1 institutional shareholders have increased their position in INO stock as of 31 Mar 24 compared to 39 in the previous quarter (a -97.44% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 2 | -93.33% |
| 31 Dec, 23 | 30 | -25.00% |
| 30 Sep, 23 | 40 | -6.98% |
| 30 Jun, 23 | 43 | -17.31% |
| 31 Mar, 23 | 52 | 13.04% |
| 31 Dec, 22 | 46 | 9.52% |
| 30 Sep, 22 | 42 | 31.25% |
| 30 Jun, 22 | 32 | -45.76% |
| 31 Mar, 22 | 59 | -3.28% |
| 31 Dec, 21 | 61 | 1.67% |
| 30 Sep, 21 | 60 | 27.66% |
| 30 Jun, 21 | 47 | -12.96% |
| 31 Mar, 21 | 54 | -11.48% |
| 31 Dec, 20 | 61 | 24.49% |
| 30 Sep, 20 | 49 | 48.48% |
| 30 Jun, 20 | 33 | - |
| 31 Mar, 20 | 33 | 26.92% |
| 31 Dec, 19 | 26 | -18.75% |
| 30 Sep, 19 | 32 | 18.52% |
| 30 Jun, 19 | 27 | 3.85% |
| 31 Mar, 19 | 26 | -7.14% |
| 31 Dec, 18 | 28 | - |
| 30 Sep, 18 | 28 | -9.68% |
| 30 Jun, 18 | 31 | -11.43% |
| 31 Mar, 18 | 35 | - |
| 31 Dec, 17 | 35 | 94.44% |
| 30 Sep, 17 | 18 | -33.33% |
| 30 Jun, 17 | 27 | -15.63% |
| 31 Mar, 17 | 32 | -8.57% |
| 31 Dec, 16 | 35 | -2.78% |
| 30 Sep, 16 | 36 | -20.00% |
| 30 Jun, 16 | 45 | 36.36% |
| 31 Mar, 16 | 33 | 32.00% |
| 31 Dec, 15 | 25 | -10.71% |
| 30 Sep, 15 | 28 | 100.00% |
| 30 Jun, 15 | 14 | -39.13% |
| 31 Mar, 15 | 23 | -14.81% |
| 31 Dec, 14 | 27 | 42.11% |
| 30 Sep, 14 | 19 | - |
| 30 Jun, 14 | - | - |
2 institutional shareholders have reduced their position in INO stock as of 31 Mar 24 compared to 30 in the previous quarter (a -93.33% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 3 | -97.30% | 10,350 | -99.98% | 0.05% | 0.01% | 1 | -97.44% | 2 | -93.33% |
| 31 Dec, 23 | 111 | -11.90% | 49,831,646 | -10.29% | 18.55% | 4.20% | 39 | -9.30% | 30 | -25.00% |
| 30 Sep, 23 | 126 | -5.97% | 55,546,864 | -22.55% | 21.01% | 2.73% | 43 | -12.24% | 40 | -6.98% |
| 30 Jun, 23 | 134 | -23.86% | 71,715,080 | -41.07% | 27.75% | 1.25% | 49 | -30.00% | 43 | -17.31% |
| 31 Mar, 23 | 176 | -6.38% | 121,702,472 | -4.35% | 47.09% | 1.66% | 70 | -30.69% | 52 | 13.04% |
| 31 Dec, 22 | 188 | 11.90% | 127,241,277 | 9.78% | 53.32% | 2.47% | 101 | 31.17% | 46 | 9.52% |
| 30 Sep, 22 | 168 | 1.82% | 115,901,200 | 2.27% | 46.48% | 2.00% | 77 | -8.33% | 42 | 31.25% |
| 30 Jun, 22 | 165 | -12.23% | 113,328,803 | 23.25% | 48.17% | 2.73% | 84 | 15.07% | 32 | -45.76% |
| 31 Mar, 22 | 188 | -10.05% | 91,947,908 | 6.99% | 42.00% | 2.51% | 73 | -23.96% | 59 | -3.28% |
| 31 Dec, 21 | 209 | -4.57% | 85,941,089 | 11.04% | 40.87% | 3.02% | 96 | 7.87% | 61 | 1.67% |
| 30 Sep, 21 | 219 | -1.79% | 77,399,140 | 5.30% | 36.80% | 2.99% | 89 | -19.82% | 60 | 27.66% |
| 30 Jun, 21 | 223 | -4.29% | 73,502,159 | -1.49% | 35.07% | 2.58% | 111 | -10.48% | 47 | -12.96% |
| 31 Mar, 21 | 233 | -2.92% | 74,613,791 | 12.57% | 36.86% | 2.02% | 124 | 3.33% | 54 | -11.48% |
| 31 Dec, 20 | 240 | -3.23% | 66,280,947 | 6.39% | 42.73% | 3.01% | 120 | -14.89% | 61 | 24.49% |
| 30 Sep, 20 | 248 | 0.81% | 62,297,204 | 10.14% | 37.67% | 2.86% | 141 | -18.50% | 49 | 48.48% |
| 30 Jun, 20 | 246 | 41.38% | 56,564,042 | 28.78% | 36.30% | 2.92% | 173 | 50.43% | 33 | - |
| 31 Mar, 20 | 174 | 61.11% | 43,921,704 | -9.84% | 35.24% | 1.45% | 115 | 121.15% | 33 | 26.92% |
| 31 Dec, 19 | 108 | -6.90% | 48,717,775 | 4.47% | 49.35% | 2.22% | 52 | 20.93% | 26 | -18.75% |
| 30 Sep, 19 | 116 | -9.38% | 46,631,834 | -0.15% | 47.10% | 2.08% | 43 | -25.86% | 32 | 18.52% |
| 30 Jun, 19 | 128 | 3.23% | 46,702,815 | 2.20% | 47.62% | 2.17% | 58 | -7.94% | 27 | 3.85% |
| 31 Mar, 19 | 124 | - | 45,698,373 | 28.39% | 46.87% | 3.17% | 63 | 16.67% | 26 | -7.14% |
| 31 Dec, 18 | 124 | -5.34% | 35,594,203 | 8.92% | 38.46% | 3.08% | 54 | -18.18% | 28 | - |
| 30 Sep, 18 | 131 | 3.97% | 32,680,100 | 12.99% | 35.36% | 3.51% | 66 | 32.00% | 28 | -9.68% |
| 30 Jun, 18 | 126 | -3.08% | 28,923,247 | -3.85% | 31.73% | 2.87% | 50 | -13.79% | 31 | -11.43% |
| 31 Mar, 18 | 130 | -2.26% | 30,080,506 | 5.13% | 33.26% | 2.72% | 58 | - | 35 | - |
| 31 Dec, 17 | 133 | 1.53% | 28,613,532 | -1.54% | 34.99% | 3.13% | 58 | -21.62% | 35 | 94.44% |
| 30 Sep, 17 | 131 | 3.15% | 29,061,535 | 30.13% | 33.42% | 3.81% | 74 | 34.55% | 18 | -33.33% |
| 30 Jun, 17 | 127 | 13.39% | 22,333,039 | 11.92% | 29.62% | 4.09% | 55 | 41.03% | 27 | -15.63% |
| 31 Mar, 17 | 112 | -16.42% | 19,955,164 | -2.29% | 26.91% | 3.46% | 39 | -23.53% | 32 | -8.57% |
| 31 Dec, 16 | 134 | -1.47% | 20,421,897 | -3.38% | 27.89% | 3.38% | 51 | 15.91% | 35 | -2.78% |
| 30 Sep, 16 | 136 | -3.55% | 21,135,719 | 0.55% | 28.72% | 3.46% | 44 | -24.14% | 36 | -20.00% |
| 30 Jun, 16 | 141 | 11.90% | 21,021,112 | 4.74% | 28.81% | 3.73% | 58 | -1.69% | 45 | 36.36% |
| 31 Mar, 16 | 126 | -1.56% | 20,069,268 | -13.79% | 27.79% | 2.38% | 59 | 1.72% | 33 | 32.00% |
| 31 Dec, 15 | 128 | 8.47% | 23,280,360 | -5.53% | 34.14% | 2.92% | 58 | -6.45% | 25 | -10.71% |
| 30 Sep, 15 | 118 | 10.28% | 24,643,125 | 4.35% | 34.21% | 2.81% | 62 | -11.43% | 28 | 100.00% |
| 30 Jun, 15 | 107 | 4.90% | 23,615,259 | 25.66% | 34.90% | 3.65% | 70 | 25.00% | 14 | -39.13% |
| 31 Mar, 15 | 102 | 6.25% | 18,792,327 | 6.99% | 30.94% | 3.51% | 56 | 16.67% | 23 | -14.81% |
| 31 Dec, 14 | 96 | 9.09% | 17,564,633 | 25.80% | 29.71% | 5.56% | 48 | -12.73% | 27 | 42.11% |
| 30 Sep, 14 | 88 | 7.32% | 13,961,985 | 21.83% | 23.12% | 6.39% | 55 | -25.68% | 19 | - |
| 30 Jun, 14 | 82 | - | 11,460,081 | - | 19.03% | - | 74 | - | - | - |
Inovio Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Inovio Pharmaceuticals's stock was made by Sumner Michael John on Jul 01 2024, selling 2,917 shares at - per share (valued at -).
Inovio Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 28 | 18 | 155.56% |
| Q1 2024 | 13 | 11 | 118.18% |
| Q2 2023 | 28 | 12 | 233.33% |
| Q1 2023 | 19 | 24 | 79.17% |
| Q3 2022 | 2 | 6 | 33.33% |
| Q2 2022 | 23 | 9 | 255.56% |
| Q1 2022 | 26 | 38 | 68.42% |
| Q3 2021 | - | 1 | - |
| Q2 2021 | 23 | 20 | 115.00% |
| Q1 2021 | 35 | 52 | 67.31% |
| Q4 2020 | 4 | 8 | 50.00% |
| Q3 2020 | 1 | 4 | 25.00% |
| Q2 2020 | 19 | 11 | 172.73% |
| Q1 2020 | 24 | 28 | 85.71% |
| Q4 2019 | 1 | 1 | 100.00% |
| Q3 2019 | 1 | 1 | 100.00% |
| Q2 2019 | 20 | 12 | 166.67% |
| Q1 2019 | 27 | 28 | 96.43% |
| Q4 2018 | 3 | 4 | 75.00% |
| Q3 2018 | 2 | 5 | 40.00% |
28 total buy trades, and 18 total sell trades (buy/sell ratio of 1.56%) were made by Inovio Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | 2 | - |
| Q3 2022 | - | 2 | - |
| Q2 2022 | - | 2 | - |
| Q1 2022 | - | 5 | - |
| Q3 2021 | - | 1 | - |
| Q2 2021 | - | 11 | - |
| Q1 2021 | - | 16 | - |
| Q4 2020 | - | 3 | - |
| Q3 2020 | - | 3 | - |
| Q2 2020 | - | 4 | - |
| Q1 2020 | 1 | 3 | 33.33% |
| Q4 2019 | - | - | - |
| Q3 2019 | 1 | 1 | 100.00% |
| Q2 2019 | 1 | 7 | 14.29% |
| Q1 2019 | - | - | - |
| Q4 2018 | - | 1 | - |
| Q3 2018 | - | 3 | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Inovio Pharmaceuticals's stocks.
INO Ownership FAQ
Who Owns Inovio Pharmaceuticals?
Inovio Pharmaceuticals is owned by institutional shareholders (0.05%), insiders (0.85%), and public (99.11%). The largest institutional shareholder of Inovio Pharmaceuticals is IFP ADVISORS, INC (0% of total shares) and the top mutual fund owner is GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC (0.63% of total shares).
Who are the major institutional shareholders of Inovio Pharmaceuticals?
Inovio Pharmaceuticals's major institutional shareholders are IFP ADVISORS, INC, PRIME CAPITAL INVESTMENT ADVISORS, LLC, and SACHETTA, LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Inovio Pharmaceuticals shareholders are there?
As of Mar 2024, there are 3 institutional shareholders of Inovio Pharmaceuticals.
What percentage of Inovio Pharmaceuticals is owned by IFP ADVISORS, INC?
IFP ADVISORS, INC owns 0 shares of Inovio Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).
What percentage of Inovio Pharmaceuticals is owned by PRIME CAPITAL INVESTMENT ADVISORS, LLC?
As of Jun 2024, PRIME CAPITAL INVESTMENT ADVISORS, LLC holds 0 shares of Inovio Pharmaceuticals (INO), compromising 0% of the company, valued at $0.
What percentage of Inovio Pharmaceuticals is owned by SACHETTA, LLC?
SACHETTA, LLC is the third largest holder of Inovio Pharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).